The incidence and prognostic significance of cardiac arrhythmias and conduction abnormalities in patients with acute coronary syndromes and renal dysfunction

Kardiologia Polska

Volumn 69, Issue 12, 2011, Pages 1242-1247

  Lisowska, Anna ^a   Tycińska, Agnieszka ^a   Knapp, Małgorzata ^a   Lisowski, Piotr ^a   Musiał, Włodzimierz J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Acute coronary syndromes; Arrhythmias; Renal dysfunction

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HOSPITAL PATIENT; HUMAN; HYPERKALEMIA; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUPRAVENTRICULAR TACHYCARDIA; UNSTABLE ANGINA PECTORIS; ANGINA, UNSTABLE; ARRHYTHMIAS, CARDIAC; COMORBIDITY; CONGENITAL MALFORMATION; DIABETES MELLITUS, TYPE 2; HEART MUSCLE CONDUCTION SYSTEM; KIDNEY FAILURE, CHRONIC; MIDDLE AGED;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; ARRHYTHMIAS, CARDIAC; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84455175920     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Trusz-Gluza M. W leczeniu migotania przedsionków należy siȩkierować odległym rokowaniem a nie doraźnym uzyskaniem rytmu zatokowego. Kardiol Pol, 2009; 67: 183-189.
2. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis, 2005; 46: 897-902. (Pubitemid 41505464)
3. Vazquez E, Sanchez-Perales C, Lozano C et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol, 2003; 92: 868-871. (Pubitemid 37163591)
4. Vazquez E, Sanchez-Perales C, Borrego F et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J, 2000; 140: 886-890.
5. Vazquez E, Sanchez-Perales C, Garcia-Cortes M et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int J Cardiol, 2003; 87: 135-139. (Pubitemid 36135967)
6. Watanabe H, Watanabe T, Sasaki S et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J, 2009; 158: 629-636.
7. Iguchi Y, Kimura K, Kobayashi K et al. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol, 2008; 102: 1056-1059.
8. McManus D, Corteville D, Shlipak M et al. Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). Am J Cardiol, 2009; 104: 1551-1555.
9. Atar I, Konas D, Acikel S et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol, 2006; 106: 47-51. (Pubitemid 41728908)
10. Bozbas H, Atar I, Yildirir A et al. Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis. Ren Fail, 2007, 29: 331-339. (Pubitemid 46752353)
11. Ananthapanyasut W, Napan S, Rudolph E et al. Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. Clin J Am Soc Nephrol, 2010; 5: 173-181.
12. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systemic review of the incidence, clinical features and prognostic implications. Eur Heart J, 2009;30: 1038-1045.
13. Lopes RD, Pieper KS, Horton JR et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart, 2008; 94: 867-873. (Pubitemid 351914696)
14. Landmark M, Wheeler D, Lip G et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham study. Am J Kidney Dis, 2004; 43: 244-253. (Pubitemid 38146322)
15. Healey J, Baranchuk A, Crystal E et al. Prevention of atria fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol, 2005; 45: 1832-1839. (Pubitemid 40789940)
16. Sharma S, Gage B, Deych E et al. Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. Am Heart J, 2009; 157: 1057-1063.
17. Bloom H, Heeke B, Leon A et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol, 2006; 29: 142-145.
18. Wong CK, White HD, Wilcox RG et al. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial. Card Electrophysiol Rev, 2003; 7: 201-207. (Pubitemid 38256100)
19. Napoli C, Sorice P, Di Benedetto A et al. Propafenone in the conversion of atrial fibrillation in patients suffering from chronic renal failure. Am J Ther, 1997; 4: 130-133. (Pubitemid 27247108)
20. Nilsson KR, Al-Khatib SM, Zhou Y et al. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart, 2010; 96: 838-842.
21. Shlipak MG, Heidenreich PA, Noguchi H et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med, 2002; 137: 555-562.
22. Boliñska S, Sobkowicz B, Zaniewska J et al. The significance of anemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol, 2011; 69: 33-39.